Launch
Bayer wins FDA nod for a new kind of blood thinner
BioPharma Dive · By Jacob Bell ·
The Brief
- The FDA has approved Sunharbo, a blood thinner from Bayer.
- Sunharbo is the first approved Factor XIa inhibitor, a class of medicines that has been anticipated.
- The class is seen as a possible step forward in stroke prevention.
Why it matters
It is the first approved drug in a new class of anticoagulants that targets Factor XI, which could offer a different option for stroke prevention.
Who’s affected
- patients at risk of stroke
- clinicians who prescribe anticoagulants
- #anticoagulants
- #stroke prevention
- #factor xi
- #fda approval
- #bayer
- #drug approval
Sunharbo’s U.S. approval is the first for a “Factor XIa” inhibitor, an anticipated class of medicines seen as a possible step forward in stroke prevention.
Timeline
FDA approval of Sunharbo reported as the first Factor XIa inhibitor approved in the U.S.
BioPharma Dive - Latest News
Bayer wins FDA nod for a new kind of blood thinner